Cargando…
Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
BACKGROUND & OBJECTIVES: Tuberculosis is a major health problem in India, and the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) has further complicated the situation. Though several studies characterizing drug sensitive an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405938/ https://www.ncbi.nlm.nih.gov/pubmed/25857493 |
_version_ | 1782367689124085760 |
---|---|
author | Singh, Amit Gopinath, Krishnamoorthy Sharma, Prashant Bisht, Deepa Sharma, Pawan Singh, Niti Singh, Sarman |
author_facet | Singh, Amit Gopinath, Krishnamoorthy Sharma, Prashant Bisht, Deepa Sharma, Pawan Singh, Niti Singh, Sarman |
author_sort | Singh, Amit |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Tuberculosis is a major health problem in India, and the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) has further complicated the situation. Though several studies characterizing drug sensitive and drug resistant strains are available in literature, almost all studies are done on unrelated strains. Therefore, the objective of this study was to compare the proteomic data of four sequential isolates of Mtb from a single patient who developed MDR-TB during the course of anti-tuberculosis therapy (ATT). METHODS: In this study, using two-dimensional (2D) gel electrophoresis and MALDI-TOF mass spectrometry, we compared and analyzed the cell lysate proteins of Mtb sequential clinical isolates from a patient undergoing anti-TB treatment. The mRNA expression levels of selected identified proteins were determined by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: The genotypes of all four isolates remained homologous, indicating no re-infection. The initial isolate (before treatment) was sensitive to all first-line drugs, but the consecutive isolates were found to be resistant to isoniazid (INH) and rifampicin (RIF) and developed mutations in the katG, inhA and rpoB. The intensities of 27 protein spots were found to be consistently overexpressed in INH and RIF resistant isolates. The most prominent and overexpressed proteins found during the development of drug resistance were GarA (Rv1827), wag31 (Rv2145c), Rv1437 and Rv2970c. INTERPRETATION & CONCLUSIONS: This preliminary proteomic study provides an insight about the proteins that are upregulated during drug resistance development. These upregulated proteins, identified here, could prove useful as immunodiagnostic and possibly drug resistant markers in future. However, more studies are required to confirm these findings. |
format | Online Article Text |
id | pubmed-4405938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-44059382015-05-06 Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant Singh, Amit Gopinath, Krishnamoorthy Sharma, Prashant Bisht, Deepa Sharma, Pawan Singh, Niti Singh, Sarman Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Tuberculosis is a major health problem in India, and the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) has further complicated the situation. Though several studies characterizing drug sensitive and drug resistant strains are available in literature, almost all studies are done on unrelated strains. Therefore, the objective of this study was to compare the proteomic data of four sequential isolates of Mtb from a single patient who developed MDR-TB during the course of anti-tuberculosis therapy (ATT). METHODS: In this study, using two-dimensional (2D) gel electrophoresis and MALDI-TOF mass spectrometry, we compared and analyzed the cell lysate proteins of Mtb sequential clinical isolates from a patient undergoing anti-TB treatment. The mRNA expression levels of selected identified proteins were determined by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: The genotypes of all four isolates remained homologous, indicating no re-infection. The initial isolate (before treatment) was sensitive to all first-line drugs, but the consecutive isolates were found to be resistant to isoniazid (INH) and rifampicin (RIF) and developed mutations in the katG, inhA and rpoB. The intensities of 27 protein spots were found to be consistently overexpressed in INH and RIF resistant isolates. The most prominent and overexpressed proteins found during the development of drug resistance were GarA (Rv1827), wag31 (Rv2145c), Rv1437 and Rv2970c. INTERPRETATION & CONCLUSIONS: This preliminary proteomic study provides an insight about the proteins that are upregulated during drug resistance development. These upregulated proteins, identified here, could prove useful as immunodiagnostic and possibly drug resistant markers in future. However, more studies are required to confirm these findings. Medknow Publications & Media Pvt Ltd 2015-01 /pmc/articles/PMC4405938/ /pubmed/25857493 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Singh, Amit Gopinath, Krishnamoorthy Sharma, Prashant Bisht, Deepa Sharma, Pawan Singh, Niti Singh, Sarman Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant |
title | Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant |
title_full | Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant |
title_fullStr | Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant |
title_full_unstemmed | Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant |
title_short | Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant |
title_sort | comparative proteomic analysis of sequential isolates of mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405938/ https://www.ncbi.nlm.nih.gov/pubmed/25857493 |
work_keys_str_mv | AT singhamit comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant AT gopinathkrishnamoorthy comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant AT sharmaprashant comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant AT bishtdeepa comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant AT sharmapawan comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant AT singhniti comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant AT singhsarman comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant |